About
Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. It was acquired by Hologic, Inc in March 2021. The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, the industry’s most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.
At Diagenode, our goal is to build products with pride and the highest level of performance. Our team of epigenetics experts develop products by getting feedback from our customers as well as the scientific and medical communities around us. We strive to develop superior and easy-to-use products to bring epigenetics research and diagnostics to new frontiers.
Role in METHYLOMIC project
Diagenode has strong expertise in epigenetics with a focus in DNA methylation biomarker discovery and validation.
For that reason, it has been chosen as the official service provider for setting up the NGS high-throughput DNA methylation assay that will be used in METHYLOMIC clinical trial.